Overview

PharmacoMRI of Parkinson Disease

Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
Based on studies showing better responsiveness of motor versus cognitive symptoms to Parkinson's Disease medication, also known as dopaminergic treatments, the investigators hypothesize that comparison of resting state networks in the on versus off medication state in Parkinson's Disease patients will show greater effects on brain networks associated with motor control.
Phase:
N/A
Details
Lead Sponsor:
Northwestern University
Treatments:
Carbidopa
Carbidopa, levodopa drug combination
Levodopa